These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23598716)

  • 1. Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.
    Marquez E; Geng Z; Pass S; Summerour P; Robinson L; Sarode V; Gupta S
    Genet Med; 2013 Dec; 15(12):925-32. PubMed ID: 23598716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
    Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
    Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
    Dow E; Buchanan DD; Winship IM
    Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Hall MJ
    J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
    Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
    Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients.
    Zumstein V; Vinzens F; Zettl A; Heinimann K; Koeberle D; von Flüe M; Bolli M
    Swiss Med Wkly; 2016; 146():w14315. PubMed ID: 27152634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
    Batte BA; Bruegl AS; Daniels MS; Ring KL; Dempsey KM; Djordjevic B; Luthra R; Fellman BM; Lu KH; Broaddus RR
    Gynecol Oncol; 2014 Aug; 134(2):319-25. PubMed ID: 24933100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
    Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
    Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
    Carwana H; Hoodfar E; Bergoffen J; Li D
    Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.
    Kidambi TD; Blanco A; Myers M; Conrad P; Loranger K; Terdiman JP
    Dig Dis Sci; 2015 Aug; 60(8):2463-9. PubMed ID: 24903654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort.
    Loh Z; Williams DS; Salmon L; Dow E; John T
    Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
    Han J; Spigelman AD
    ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
    Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
    J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
    Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
    BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.